Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Creator
-
Seung, E.
- Contributor
-
Dugast, A.
Dudek, T.
Mattoo, H.
Vrbanac, V.
Tivey, T.
Murooka, T.
Cariappa, A.
Luster, AD
Pillai, S.
Tager, AM
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P60
- URN
-
urn:nbn:de:1111-2016080728530
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Seung, E.
- Dugast, A.
- Dudek, T.
- Mattoo, H.
- Vrbanac, V.
- Tivey, T.
- Murooka, T.
- Cariappa, A.
- Luster, AD
- Pillai, S.
- Tager, AM
- SpringerLink (Online service)
Other Objects (12)
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Model-based anti-HIV therapy
Dual anti-HIV mechanism of clofarabine
Universal access to anti-HIV therapy
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
Anti-HIV nucleosides : past, present and future
P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
Anti-HIV and immune modulating activities of IND02
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
Nanomedicine perspective in HIV therapy: biosynthesized gold nanoparticles exhibiting enhanced anti-HIV property
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Model-based anti-HIV therapy
Dual anti-HIV mechanism of clofarabine
Universal access to anti-HIV therapy
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
Anti-HIV nucleosides : past, present and future
P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
Anti-HIV and immune modulating activities of IND02
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
Nanomedicine perspective in HIV therapy: biosynthesized gold nanoparticles exhibiting enhanced anti-HIV property
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Model-based anti-HIV therapy
Dual anti-HIV mechanism of clofarabine
Universal access to anti-HIV therapy
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
Anti-HIV nucleosides : past, present and future
P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
Anti-HIV and immune modulating activities of IND02
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity